OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 16.04.2026, 08:31

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

Artificial Intelligence in Cardiovascular Pathology: Toward a Diagnostic Revolution

2026·0 Zitationen·BioMedInformaticsOpen Access
Volltext beim Verlag öffnen

0

Zitationen

4

Autoren

2026

Jahr

Abstract

Artificial intelligence (AI) in cardiovascular pathology involves the use of computational models, including machine learning and deep learning (DL), to analyse complex and heterogeneous data. These data include histopathological whole-slide images, cardiovascular imaging techniques such as cardiac magnetic resonance, echocardiography, computed tomography (CT), clinical parameters, and molecular information. The integration of these multimodal data sources allows AI to overcome the limitations of single-modality analysis, improving diagnostic accuracy, prognostic stratification, and personalised clinical decision-making while reducing inter-observer variability. Cardiovascular disease remains the leading cause of mortality worldwide, highlighting the need for more precise and timely diagnostic tools. AI has shown significant promise, particularly in digital pathology, where the digitisation of histological slides combined with advanced algorithms enables improved diagnosis, prognostic assessment, and translational research. This review summarises current AI applications in cardiovascular pathology, focusing on heart transplant rejection, cardiomyopathies, myocarditis, and atherosclerotic and valvular diseases. Automated methods offer important advantages, including diagnostic standardisation, quantitative histological analysis, and improved reproducibility. However, several challenges remain, such as the need for large, well-annotated shared datasets, limited interpretability of AI models, and ethical and legal issues related to clinical implementation. AI represents a promising tool for advancing cardiovascular pathology and personalised medicine, although robust multicentre validation is required before routine clinical adoption.

Ähnliche Arbeiten

Autoren

Institutionen

Themen

Artificial Intelligence in Healthcare and EducationAI in cancer detectionCardiovascular Disease and Adiposity
Volltext beim Verlag öffnen